AsiaPay enters partnership with buy now pay later platform Atome

 Hong Kong-based computerized payment arrangements supplier AsiaPay has gone into another organization with 'buy now pay later' stage Atome.

The organization will empower adaptable portion payment acknowledgment at on the web and disconnected retail organizations across the Asia-Pacific (APAC) area.

Especially, the joint effort will look to smooth out incorporation to improve 'buy now pay later' payment accommodation and acknowledgment at checkouts across disconnected and online channels.

AsiaPay President Joseph Chan said: "The get towards computerized payments across Asia is speeding up and there is expanding vendor interest for a total coordinated payment acknowledgment answer for streamline deals and business transformation.

"Buy now, pay later market plans are filling in prevalence among clients in Asia who are looking for more monetary adaptability while shopping either coming up or on the web. We are excited to collaborate with Atome who can upgrade the business transformation of dealers in Asia with BNPL comfort and furnish vendors with an adaptable payment elective that supports client experience."

Sent off in 2019, Atome is a main 'buy now pay later' innovation organization situated in Singapore.

It counts more than 2,000 on the web and disconnected retailers in six markets (Singapore, Indonesia, Malaysia, Hong Kong, Vietnam and central area China) as its accomplices.

For more insights on the BNPL market, download a free report sample

Atome Chief David Chen said: "Now, like never before, purchasers need adaptability, straightforwardness and a superior, more customized shopping and payment experience.

"This thrilling organization with AsiaPay will uphold large number of organizations across the district in empowering a predominant, consistent checkout experience for shoppers, both coming up and online sites."

Last month, AsiaPay cooperated with Speed to work with buy now, pay later portion payment administration for Australian traders.

Comments

Post a Comment

Popular posts from this blog

ETView wins Chinese approval for VivaSight-SL airway management device

The Chinese State Food and Drug Organization (SFDA) ihas cleared the pre-marketing warning application for ETView Clinical's VivaSight-SL airway management devices market . The gadget, which is remembered for the organization's protected VivaSight airway management portfolio, is a solitary utilize expendable single lumen ventilation tube with a coordinated constant high goal video imaging framework, for use in lung separation systems like thoracic, cardiovascular, vascular or esophageal medical procedures. The organization, which expects extra pre-market administrative clearances during 2013, said the gadget will be dispersed all through China by Sinopharm. ETView President Bill Edelman said the organization expects huge clinical interest where the item is cleared for business circulation. "With our line of VivaSight items accessible in the US, South America, Europe and presently China, ETView offers a total airway management answer for 100 percent of lung-confinement medi...
Read more

MRI-based imaging technology avoids contrast agents

A research group at Purdue College in the US has fostered another scientific imaging innovation that eliminates the requirement for contrast agents to recognize and screen cerebral vascular issues and injuries in the brain. The new methodology depends on practical X-ray and searches for an intrinsic blood-related X-ray signal, which is utilized as a characteristic biomarker to follow blood stream in a patient. Cerebral course time is the defer that happens during the movement of intrinsic signs from the internal carotid supply route to the internal jugular vein. A drawn out time delay is seen as blood stream unsettling influence in the brain, possibly because of a cancer, horrendous brain injury or other brain illnesses. Purdue College Weldon School of Biomedical Engineering colleague teacher Yunjie Tong said: "We can think about the sign from symmetric supply routes and veins in the two halves of the globe or neck to survey the cerebrovascular integrity or the equilibrium of bloo...
Read more

RUSSIA: Cherkizovo profits up 17% in Q1

Russian seasonings, dressings and sauces market processor Cherkizovo has detailed an expansion in benefits for the primary quarter yet said its outcomes were impacted via occasional elements and a "more tight" evaluating climate. Total compensation for the quarter finished 31 March expanded 17% to arrive at US$31m. Incomes rose 14% on a rouble money premise, and expanded 29% to $268m in the quarter. Changed EBITDA for the three-month time frame was up 13% on a rouble money premise, and 28% to $48.1m. The firm said it will currently move to quarterly monetary detailing in a bid to "further develop straightforwardness and corporate administration" in the gathering. "For the ongoing year we remain comprehensively certain on Russian utilization, and we anticipate that the valuing climate should improve towards the final part of the year, remaining extensively positive from there on," the organization said.
Read more